Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15,690 INR | 0.00% | +0.07% | -9.58% |
May. 01 | Procter & Gamble Hygiene Posts Decline in Fiscal Q4 Net Profit | MT |
Apr. 30 | Procter & Gamble Hygiene & Health Care's Net Profit Slips in Fiscal Q4 | MT |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.58% | 6.1B | C | ||
+13.58% | 143B | B- | ||
+18.09% | 77.23B | A+ | ||
-12.61% | 65.42B | A- | ||
-7.86% | 48.32B | B+ | ||
-4.92% | 39.2B | - | ||
+6.63% | 35.21B | B- | ||
+11.64% | 18.31B | A- | ||
+14.87% | 15.9B | B | ||
-3.09% | 11.4B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
- Stock Market
- Equities
- PGHH Stock
- Ratings Procter & Gamble Hygiene and Health Care Limited